The existence of a biosimilar within a six-month window can prevent a health plan from entering into a long-term contract with a brand-name manufacturer. This strategic hesitation underscores a broader shift in the pharmaceutical industry where the velocity of regulatory approvals is no longer the
Effective market access now requires a long-term commitment to providing evolving evidence that reflects the changing priorities of formulary committees and health systems. This reality fundamentally challenges the long-held industry assumption that payers perform a cursory, one-time review of
The transition into the catastrophic coverage phase now requires beneficiaries to reach a higher spending threshold of $2,400 before their cost-sharing obligations end. This specific modification represents a broader realignment of the Medicare landscape as the federal government and private
Healthcare utilization rates have surged beyond insurer expectations, leading to more restrictive provider networks and the termination of less profitable policies. This volatility is defining the start of the 2027 enrollment season, as over three million seniors find themselves navigating a
A staggering 32.7 percent of Medicaid enrollees at risk of losing coverage report being in poor physical health despite not meeting official criteria for a disability exemption. This critical finding underscores a growing crisis in the American healthcare landscape following the implementation of
The proposed legislation would eliminate the existing tug-of-war between insurers and doctors by pegging future out-of-network payments to inflation-adjusted 2019 median rates. Representative Frank Pallone Jr. introduced this bold measure, known as the Lower Premiums, Faster Payments Act, to
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32